Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma
NCT01689766 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2023-07-25
Summary
Phase 2, multi-center, open-label, single-treatment group, baseline-controlled study to identify subjects with Folate Receptor-Positive Metastatic Renal Cell Carcinoma
Conditions
- Metastatic Renal Cell Carcinoma
Interventions
- DRUG
-
Technetium Tc 99m EC20
Sponsors & Collaborators
-
Endocyte
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-11-30
- Primary Completion
- 2007-11-30
Countries
- United States
Study Locations
More Related Trials
-
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
NCT00001503 ·Status: COMPLETED
-
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
NCT04883827 ·Status: COMPLETED
-
Measurement of the Folate Receptor in Blood
NCT00838747 ·Status: COMPLETED
-
Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease
NCT02781025 ·Status: COMPLETED
-
Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
NCT00896675 ·Status: COMPLETED
-
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02092714 ·Status: UNKNOWN
-
Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
NCT06877910 ·Status: ACTIVE_NOT_RECRUITING
-
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors
NCT01987726 ·Status: COMPLETED
-
Tumor-Derived FGF19
NCT06068257 ·Status: RECRUITING
-
Molecular Screening for Cancer Treatment Optimization
NCT01566019 ·Status: UNKNOWN ·Phase: NA
-
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
NCT06666634 ·Status: RECRUITING ·Phase: NA
-
Role of Serum Regucalcin in Diagnosis of Hepatocellular Carcinoma
NCT03206866 ·Status: UNKNOWN
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors
NCT00672269 ·Status: UNKNOWN
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
NCT07224750 ·Status: RECRUITING
-
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
NCT07243067 ·Status: NOT_YET_RECRUITING
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
NCT03871816 ·Status: COMPLETED
-
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
NCT00900276 ·Status: COMPLETED
-
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
NCT04137523 ·Status: COMPLETED
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450448 ·Status: COMPLETED
-
CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer with Leptomeningeal Disease
NCT05257967 ·Status: RECRUITING ·Phase: NA